Over-sized stenting in primary percutaneous coronary intervention

Comparison of the effectiveness of over-sized stenting versus conventional stenting in patients undergoing primary percutaneous coronary intervention

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190411043242N1

Enrollment

Registered

2019-08-29

Start date

2018-09-23

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient with acute myocardial infarction undergoing primary coronary angioplasty. ST elevation (STEMI) myocardial infarction of unspecified site

Interventions

Intervention 1: Intervention group: oversized stenting. In interventional group, after diagnostic angiography, intracoronary nitroglycerin will be injected and infarcted vessel size in the proximal a

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with acute myocardial infarction with >0.1 mV ST-segment elevation from baseline in at least two contiguous leads on the 12-lead electrocardiogram who were candidate for primary percutaneous intervention

Exclusion criteria

Exclusion criteria: Primary percutaneous coronary intervention without stenting Primary percutaneous coronary intervention of saphenus vein graft Rescue Primary percutaneous coronary intervention stent thrombosis myocardial infarction Electrocardiogram data inadequate to measure ST resolution

Design outcomes

Primary

Measure	Time frame
Cardiac enzyme level. Timepoint: twelve hours after procedure. Method of measurement: Lab kit.;ST segment resolution. Timepoint: 60 minute after procedure. Method of measurement: electrocardiogram.;No Reflow phenomenon. Timepoint: after stent implantation. Method of measurement: angiography.;Hospital stay. Timepoint: hospital course. Method of measurement: patient profile.	—

Secondary

Measure	Time frame
Target vessel revascularization. Timepoint: six months after intervention. Method of measurement: Medical record.;Reinfarction. Timepoint: six months after intervention. Method of measurement: Medical record.;Cardiovascular death. Timepoint: six months after intervention. Method of measurement: Medical record.;All cause death. Timepoint: six months after intervention. Method of measurement: Medical record.;Congestive heart failure. Timepoint: six months after intervention. Method of measurement: Medical record.;Cardiovascular accident. Timepoint: six months after intervention. Method of measurement: Medical record.	—

Measure

Time frame

Target vessel revascularization. Timepoint: six months after intervention. Method of measurement: Medical record.;Reinfarction. Timepoint: six months after intervention. Method of measurement: Medical record.;Cardiovascular death. Timepoint: six months after intervention. Method of measurement: Medical record.;All cause death. Timepoint: six months after intervention. Method of measurement: Medical record.;Congestive heart failure. Timepoint: six months after intervention. Method of measurement: Medical record.;Cardiovascular accident. Timepoint: six months after intervention. Method of measurement: Medical record.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyed Ali Banifatemeh

Rajaie cardiovascular medical and research center

Banifatemeh_cardio@yahoo.com+98 21 2266 3249

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026